Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Treatment.com AI Inc TREIF


Primary Symbol: C.TRUE

Treatment.com AI Inc., through its wholly owned subsidiary, Treatment.com Inc., is in the business of providing personalized health care information. The Company has developed a personalized healthcare artificial intelligence (AI) engine, the Global Library of Medicine (GLM), which is engaged in providing clinical information and support to all healthcare professionals. The GLM delivers over 92... see more

Recent & Breaking News (CSE:TRUE)

Repeat: Treatment.com AI Announces New Additions to its Medical Education Suite (MES)

GlobeNewswire 9 days ago

Treatment.com AI Announces New Additions to its Medical Education Suite (MES)

GlobeNewswire 9 days ago

Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM)

GlobeNewswire April 10, 2024

Treatment.com AI welcomes the Federal Government's announcement of a plan to fund $2.4 billion in its upcoming budget towards Artificial Intelligence (AI) Adoption

GlobeNewswire April 8, 2024

Treatment.com AI Funded by the National Institute of Health to Develop a Culturally Sensitive AI Approach to Health Equity

GlobeNewswire March 27, 2024

Treatment AI Passes Medical School Clinical Exam with 92% Success Rate

GlobeNewswire March 20, 2024

TREATMENT.COM AI INC. CLOSES OVER-SUBSCRIBED NON-BROKERED PRIVATE PLACEMENT OF $2,908,200

GlobeNewswire March 14, 2024

Treatment.com AI Provides Corporate Update

GlobeNewswire February 29, 2024

TREATMENT.COM AI INC. APPOINTS CHIEF FINANCIAL OFFICER

GlobeNewswire February 7, 2024

Treatment.com Announces New Name and Change of Officers

TheNewsWire October 31, 2023

Treatment.com Appoints Dr. Essam Hamza as CEO and Director

TheNewsWire October 18, 2023

CSE Bulletin: Consolidation - Treatment.com International Inc. (TRUE)

Newsfile July 11, 2023

Treatment's Debut AI-driven Health App Getting Five Star Reviews from Doctors

GlobeNewswire April 6, 2022

Treatment Announces Convertible Debenture Private Placement

GlobeNewswire March 28, 2022

Treatment's (CSE:TRUE) Digital Health App now available on Google Play Store

Caroline Egan  February 17, 2022

Treatment's Doctor-Built Digital Health App now on Google Play Store

GlobeNewswire February 17, 2022

Treatment Launches Landmark Doctor Built Digital Health App

GlobeNewswire January 24, 2022

Treatment to Expand Global Library of Medicine with Dermatologic Diseases

GlobeNewswire January 4, 2022

Treatment Signs Ocean Medical Agreement For The AI Driven Doctors Office

GlobeNewswire December 16, 2021

Treatment Announces Beta Release of Landmark Doctor Built Digital Health App

GlobeNewswire November 30, 2021